| Teuvincenone F Suppresses LPS-Induced Inflammation and NLRP3 Inflammasome Activation by Attenuating NEMO Ubiquitination | |
Zhao, Xibao1,2; Pu, Debing3,4 ; Zhao, Zizhao2; Zhu, Huihui2; Li, Hongrui1,2; Shen, Yaping2; Zhang, Xingjie3; Zhang, Ruihan3; Shen, Jianzhong5; Xiao, Weilie3,4; Chen, Weilin1,2
| |
| 2017-08-23 | |
| Source Publication | FRONTIERS IN PHARMACOLOGY
 |
| ISSN | 1663-9812 |
| Volume | 8Pages:565 |
| Abstract | Inflammation causes many diseases that are serious threats to human health. However, the molecular mechanisms underlying regulation of inflammation and inflammasome activation are not fully understood which has delayed the discovery of new anti-inflammatory drugs of urgent clinic need. Here, we found that the natural compound Teuvincenone F, which was isolated and purified from the stems and leaves of Premna szemaoensis, could significantly inhibit lipopolysaccharide (LPS)-induced pro-inflammatory cytokines production and NLRP3 inflammasome activation. Our results showed that Teuvincenone F attenuated K63-linked ubiquitination of NF-kappa B-essential modulator (NEMO, also known as IKK gamma) to suppress LPS-induced phosphorylation of NF-kappa B, and inhibited mRNA expression of IL-1 beta, IL-6, TNF-alpha, and NLRP3. In addition, we found that decreased NLRP3 expression by Teuvincenone F suppressed NLRP3 inflammasome activation and IL-1 beta/IL-18 maturation. In vivo, we revealed that Teuvincenone F treatment relieved LPS-induced inflammation. In conclusion, Teuvincenone F is a highly effective natural compound to suppress LPS-induced inflammation by attenuating K63-linked ubiquitination of NEMO, highlighting that Teuvincenone F may be a potential new anti-inflammatory drug for the treatment of inflammatory and NLRP3 inflammasome-driven diseases. |
| Keyword | Teuvincenone f Inflammation Nlrp3 Inflammasome Ubiquitination Nemo |
| Subject Area | Pharmacology & Pharmacy |
| DOI | 10.3389/fphar.2017.00565 |
| Indexed By | SCI |
| Language | 英语 |
| WOS ID | WOS:000408517500001 |
| Citation statistics | |
| Document Type | 期刊论文 |
| Identifier | http://ir.kib.ac.cn/handle/151853/54914 |
| Collection | 植物化学与西部植物资源持续利用国家重点实验室 |
| Affiliation | 1.Shenzhen Univ, Dept Immunol, Sch Med, Shenzhen, Peoples R China 2.Zhejiang Univ, Inst Immunol, Dept Basic Med, Sch Med, Hangzhou, Zhejiang, Peoples R China 3.Yunnan Univ, Key Lab Med Chem Nat Resource, Minist Educ, Sch Chem Sci & Technol, Kunming, Yunnan, Peoples R China 4.Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming, Yunnan, Peoples R China 5.Auburn Univ, Dept Drug Discovery & Dev, Harrison Sch Pharm, Auburn, AL 36849 USA |
| Recommended Citation GB/T 7714 | Zhao, Xibao,Pu, Debing,Zhao, Zizhao,et al. Teuvincenone F Suppresses LPS-Induced Inflammation and NLRP3 Inflammasome Activation by Attenuating NEMO Ubiquitination[J]. FRONTIERS IN PHARMACOLOGY,2017,8:565. |
| APA | Zhao, Xibao.,Pu, Debing.,Zhao, Zizhao.,Zhu, Huihui.,Li, Hongrui.,...&Chen, Weilin.(2017).Teuvincenone F Suppresses LPS-Induced Inflammation and NLRP3 Inflammasome Activation by Attenuating NEMO Ubiquitination.FRONTIERS IN PHARMACOLOGY,8,565. |
| MLA | Zhao, Xibao,et al."Teuvincenone F Suppresses LPS-Induced Inflammation and NLRP3 Inflammasome Activation by Attenuating NEMO Ubiquitination".FRONTIERS IN PHARMACOLOGY 8(2017):565. |
| Files in This Item: | Download All | |||||
| File Name/Size | DocType | Version | Access | License | ||
| fphar-08-00565.pdf（3100KB） | 期刊论文 | 作者接受稿 | 开放获取 | CC BY-NC-SA | View Download | |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment